Updates to the HTA Review Research and Analysis papers collection: Draft HTA expert paper published

Page last updated: 22 November 2023

The draft paper Optimising the availability and use of real world data and real world evidence to support health technology assessment in Australia developed to support the deliberations of the HTA Review Reference Committee, has been published on the HTA Review Research and Analysis papers webpage.

This paper has been prepared by the Medicines Intelligence Centre of Research Excellence (MI-CRE) for the Department of Health and Aged Care to support the HTA Review. This two-part report provides an overview of the current ‘state-of-play’ regarding Real World Data (RWD) availability and access, and identifies opportunities for optimising the use of RWD and real world evidence more broadly to support HTA in Australia. It concludes with a series of high-level short-, medium-, and long-term steps to realise those opportunities. In particular, the paper focuses on HTA for medicines and vaccines for listing on the Pharmaceutical Benefits Scheme and related technologies for listing on the Medicare Benefits Scheme.

The HTA Policy and Methods Review is informed by papers analysing contemporary research, relevant methodologies and purchasing practices used by comparable international jurisdictions, and applicability to the Australian context.

If you have any questions relating to the HTA Review, please email HTAReviewConsult@health.gov.au.